# Bayesian Update: Post-Tier 1 - DBS Bank

**Bank**: DBS Bank Ltd.
**Phase**: 7 (Emerging Markets)
**Date**: 2025-12-21

---

## Prior Probability

| Classification | Prior | Rationale |
|---------------|-------|-----------|
| ARCHITECT | 15% | Asian regional bank, medium derivatives relevance |
| PRAGMATIST | 45% | Likely regulatory-driven approach |
| OBSERVER | 35% | Limited CDM visibility expected |
| UNKNOWN | 5% | Singapore bank with digital focus |

**Starting Point**: 50% PRAGMATIST (null hypothesis per CLAUDE.md)

---

## Tier 1 Evidence Impact

### DBS-E001: ISDA Board Membership
- **Finding**: Andrew Ng serves on ISDA Board of Directors
- **Impact**: +15% OBSERVER (industry participation without technical adoption)
- **Rationale**: Board membership indicates governance engagement but not CDM-specific adoption

### DBS-E003: ISDA DRR Singapore Availability
- **Finding**: ISDA DRR extended to Singapore October 2024
- **Impact**: Contextual only (availability ≠ adoption)
- **Rationale**: Creates enabling environment but no adoption evidence

---

## Posterior Probability

| Classification | Prior | Update | Posterior |
|---------------|-------|--------|-----------|
| ARCHITECT | 15% | -5% | 10% |
| PRAGMATIST | 45% | -10% | 35% |
| OBSERVER | 35% | +15% | 50% |
| UNKNOWN | 5% | 0% | 5% |

**Post-Tier 1 Leading Hypothesis**: OBSERVER (50%)

---

## Key Observations

1. **ISDA Board Presence**: Strong evidence of industry governance participation
2. **No CDM Technical Evidence**: Board membership ≠ CDM adoption
3. **Regulatory Context**: MAS Rewrite creates pressure but no CDM response visible
4. **FINOS Absence**: Not a FINOS member (checked)

---

*Bayesian update completed under CDM Research Protocol v2.3*
